Fwd: Request for Inputs on PSR Recommendations under Proposed FTAs with Israel and EAEU

[Rajat Kapoor (ADMI-Secretariat)]

Dear Members,

Greetings from ADMI.

Please find below an important communication received from EPCMD regarding Product Specific Rules (PSR) recommendations in the context of the Free Trade Agreements (FTAs) currently under negotiation with Israel and the Eurasian Economic Union (EAEU).

The Department of Pharmaceuticals has proposed the following PSR recommendations for medical devices:

Category	Chapter	Total TLs	Department of Pharmaceuticals’ PSR recommendation
Medical devices	30	21	Six-digit HSN code change OR 35-40% value addition. Value addition not to exceed 45% during negotiations. ·         Six-digit HSN code change requirement not to be diluted to four-digit HSN code change during negotiations
	37	1
	38	7
	39	2
	40	5
	62	5
	84	1
	90	101
	94	4
	96	5

In this regard, members are requested to kindly provide their inputs/comments particularly with respect to:

• Feasibility of compliance by the domestic industry
• Any sensitivities or concerns involved
• Justification for the proposed rules
• Prevailing industry practices and relevant international benchmarks

Your valuable inputs will help in consolidating the industry’s perspective on the matter and supporting effective representation before the concerned authorities.

Members are requested to kindly share their inputs/comments with the ADMI Secretariat by tomorrow, 21st May 2026, for onward submission.

Best regards,

Rajat Kapoor Assistant Director – Secretariat, Association of Diagnostics Manufacturers of India, TR-217, 2nd Floor, AltF 101 Okhla, NH-19, CRRI, Ishwar Nagar, New Delhi-110044 secre...@admi-india.org | +91 95993 58095

---------- Forwarded message ---------
From: ravi gautam <ravi....@epcmd.in>
Date: Tue, May 19, 2026 at 5:49 PM
Subject: Request for Inputs on PSR Recommendations under Proposed FTAs with Israel and EAEU
To: sankalp bhatia <sankalp...@epcmd.in>

Dear Sir/ Ma'am,

Greetings from the EPCMD!

This is with reference to the trail mail on the above-mentioned subject. In this regard, it is apprised that inputs/comments on the Product Specific Rule (PSR) recommendations mentioned below are being sought in the context of the Free Trade Agreements (FTAs) currently under negotiation with Israel and the Eurasian Economic Union (EAEU). 



Category	Chapter	Total TLs	Department of Pharmaceuticals’ PSR recommendation
Medical devices	30	21	Six-digit HSN code change OR 35-40% value addition. Value addition not to exceed 45% during negotiations. ·         Six-digit HSN code change requirement not to be diluted to four-digit HSN code change during negotiations
	37	1
	38	7
	39	2
	40	5
	62	5
	84	1
	90	101
	94	4
	96	5

In this regard, you are requested to kindly provide your inputs/comments on the aforesaid PSR recommendations, particularly with respect to:

• Feasibility of compliance by the domestic industry
• Any sensitivities or concerns involved
• Justification for the proposed rules
• Prevailing industry practices and relevant international benchmarks

Your valuable inputs will greatly assist in consolidating the industry's perspective on the matter.

With Regards,
Ravi Gautam

[Rajat Kapoor (ADMI-Secretariat)]

Dear Members,

Greetings from ADMI.

This is a gentle reminder regarding the request for inputs/comments on the Product Specific Rules (PSR) recommendations shared by EPCMD in the context of the Free Trade Agreements (FTAs) currently under negotiation with Israel and the Eurasian Economic Union (EAEU).

Members are requested to kindly share their inputs/comments particularly on the following aspects:

• Feasibility of compliance by the domestic industry
• Any sensitivities or concerns involved
• Justification for the proposed rules
• Prevailing industry practices and relevant international benchmarks

Your valuable feedback will help in consolidating the industry’s perspective for onward submission to the concerned authorities.

Kindly share your inputs with the ADMI Secretariat by today, 21st May 2026.

Best regards,